Roche and biosecurity buck the trend
This article was originally published in Clinica
Executive Summary
The latest quarterly results from the diagnostics and device sector reflect the overall sluggishness of the world economy. However, Roche continued to show healthy growth. At the other end of the scale, in the devices sector, the far smaller Meridian Medical Technologies' auto-injector system for nerve agent antidotes enabled it to cash in on the hot biosecurity market, with US and foreign government purchases from the company rising by almost 75%.